Šalis: Airija
kalba: anglų
Šaltinis: HPRA (Health Products Regulatory Authority)
INACTIVATED PORCINE PAROVIRUS, K-22 STRAIN, ERYSIPELOTHRIX RHUSIOPATHIAE (LYSED BACTERIAL CELLS), SEROTYPE 2
Merial Animal Health Limited
QI09AL01
INACTIVATED PORCINE PAROVIRUS, K-22 STRAIN, ERYSIPELOTHRIX RHUSIOPATHIAE (LYSED BACTERIAL CELLS), SEROTYPE 2
Unknown
Suspension for Injection
LM-Licensed Merchant
Porcine
Inactivated Porcine parvovirus vaccine + inactivated Erysipelothrix vaccine
Immunological - Inactivated vaccine
Authorised
2002-05-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT PARVORUVAX 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 HAI.U: equivalent to HAI antibody titres of 1 log10 in guinea-pigs after administration of the vaccine. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Suspension for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Gilts, sows and boars. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of breeding pigs (sows, gilts and boars) against porcine parvovirosis, to reduce the number of stillbirths and mummified piglets, and against erysipelas to reduce or prevent clinical symptoms. The onset of immunity is obtained from 2 to 3 weeks after the primary vaccination. A duration of immunity up to 9 months and 11 months following vaccination has been proven for the parvovirus component and the erysipelas component, respectively. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Primary vaccination against porcine parvovirosis should not be carried out in the presence of maternally derived antibodies. Vaccinate only healthy animals. Each 2-ml dose of vaccine contains: Inactivated Porcine Parvovirus, K-22 strain 2 HAI.U _Erysipelothrix rhusiopathiae_ (lysed bacterial cells), serotype 2 1 Elisa U Aluminium hydroxide (expressed in Al +++ ) 4.2 mg Thiomersal 0.2 mg H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _6_ _/_ _0_ _2_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _5_ _8_ _5_ Perskaitykite visą dokumentą